GenomeFrontier’s founder/CEO/CSO, Sareina Wu, was invited as an expert speaker at the Antibody Therapeutic Conference (ATC) (November 15, 2022)
2022-11-18Our founder/CEO/CSO, Sareina Wu, was an invited speaker at the Cell and Gene Therapy World Asia 2022 conference in Singapore. (September 14-15, 2022)
2022-07-12
The title of Sareina’s presentation was Quantum pBac™: A Virus-Free Vector System for Next-Generation Cell & Gene Therapy
• Quantum pBac™ is the most efficient and potentially safer piggyBac system for use in gene therapy
• Quantum pBac™ is a superior vector for CAR-T engineering ensuring a high percentage of CAR+ TSCM CAR-T product
• Quantum pBac™ displays a safe integration profile in CAR-T cell products
The title of Karen’s presentation was qCART™, A Technology Breakthrough for Virus-Free Multiplex CAR-T Development & Manufacturing
• qCART™ system shortens the innovation cycle for development of disruptive CAR-Ts to treat solid tumors
• qCART™rejuvenates the T cells of patients with B cell malignancy
• qCART™ enables high quality multiplex and virus-free CAR-T cell manufacturing
